Not FDA-approved
Bones & muscles
Thymosin beta-4
Evidence
Limited human data
Class
Actin-binding peptide of 43 amino acids
KEY TAKEAWAY
Thymosin beta-4 is a 43-amino-acid peptide found in nearly all cells. It is the parent of TB-500, a fragment sold online. Thymosin beta-4 is not FDA-approved. Clinical trials of a synthetic version in eye conditions have not led to approval.
Written by the Veylo editorial team · Updated
November 2026
What it is
Actin-binding peptide of 43 amino acids
Main uses
Studied in eye-surface injury, wounds and heart repair; none approved
Key fact
Thymosin beta-4 is not FDA-approved. Clinical trials of a synthetic version in eye conditions have not led to approval.
Route
Eye drops or injection in studies
Evidence strength
Limited human data
Thymosin beta-4 is a 43-amino-acid peptide found in nearly all cells. It is the parent of TB-500, a fragment sold online.
It binds actin and helps cells move and repair tissue. Laboratory studies suggest it supports new blood vessel growth and wound healing.
Thymosin beta-4 is not FDA-approved. Clinical trials of a synthetic version in eye conditions have not led to approval.
Studied in eye-surface injury, wounds and heart repair; none approved.
Small trials reported it was generally well tolerated. Long-term safety data are limited, and products sold online are not quality-checked.
Thymosin beta-4: see PubMed and ClinicalTrials.gov for published studies and registered trials. No FDA drug label exists for the uses described.
Veylo content is educational and not medical advice. Peptides that are not FDA-approved are not approved for the uses described.